Peers of Mymetics Corp (MYMX)
Side-by-side comparison
Health Care · Biotechnology
Enterprise value divided by EBITDA over the last 12 months. A common way to compare companies with different amounts of debt.
Latest EV/EBITDA
-31.98x
As of May 11, 2026
Beyond EV/EBITDA, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/EBITDA |
|---|---|
| May 11, 2026 | -31.98x |
| Apr 9, 2026 | -31.98x |
| Apr 8, 2026 | -31.98x |
| Apr 7, 2026 | -31.98x |
| Apr 6, 2026 | -31.98x |
| Apr 2, 2026 | -31.98x |
| Apr 1, 2026 | -31.98x |
| Mar 31, 2026 | -31.98x |
EV/EBITDA = Enterprise Value / EBITDA (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/EBITDA is widely used because it removes the effects of financing and non-cash accounting items.
Read the general EV/EBITDA definition, formula, and analyst usage guide.
EV/EBITDA guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison